Canadian application, no grantCanada
Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1)
CA 2372980 A1 · Owner: Cao, Jack · Inventors: Walker, Philippe; Cao, Jack; Grazzini, Eric
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists of melanin concentrating hormone (MCH). The assays are based upon the binding of MCH to the SLC-1 receptor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 19, 2000
GrantedNo grant recorded
Term endedMay 19, 2020
Patent numberCA 2372980 A1
Classification (IPC)G01N33/56 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.